Central Trust Company’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13
Closed -$510 1454
2024
Q3
$510 Buy
+13
New +$470 ﹤0.01% 1362
2022
Q1
Sell
-29
Closed -$2K 1398
2021
Q4
$2K Hold
29
﹤0.01% 1207
2021
Q3
$1K Buy
+29
New +$1.44K ﹤0.01% 1229
2020
Q2
Sell
-315
Closed -$9K 1082
2020
Q1
$9K Sell
315
-237
-43% -$9.28K ﹤0.01% 877
2019
Q4
$23K Buy
552
+65
+13% +$2.6K ﹤0.01% 802
2019
Q3
$19K Sell
487
-38
-7% -$1.51K ﹤0.01% 803
2019
Q2
$20K Hold
525
﹤0.01% 796
2019
Q1
$18K Buy
+525
New +$16.6K ﹤0.01% 786
2014
Q3
Sell
-1,065
Closed -$19K 1192
2014
Q2
$19K Buy
1,065
+100
+10% +$1.71K ﹤0.01% 851
2014
Q1
$17K Sell
965
-140
-13% -$2.36K ﹤0.01% 882
2013
Q4
$20K Buy
1,105
+25
+2% +$467 ﹤0.01% 838
2013
Q3
$20K Sell
1,080
-25
-2% -$498 ﹤0.01% 833
2013
Q2
$21K Buy
+1,105
New +$21K ﹤0.01% 777

Other funds holding G

Central Trust Company's G Position: Q4 2024 in Review

Central Trust Company sold out of Genpact (G) in Q4 2024, closing a stake of 13 shares — an estimated $510 sold.

Central Trust Company first reported a position in G in Q2 2013 and held it in 13 quarters. The position peaked at $23K in Q4 2019. 420 funds tracked by Wall St. Rank hold G as of Q4 2024.

  • Central Trust Company reported no remaining Genpact position as of Q4 2024 after selling out during the quarter.
  • Central Trust Company sold 13 Genpact shares in Q4 2024, an estimated $510.
  • Central Trust Company first reported a position in Genpact in Q2 2013 and held it in 13 quarters.
  • Central Trust Company's Genpact position peaked at $23K in Q4 2019.
  • 420 funds tracked by Wall St. Rank held Genpact as of Q4 2024.

Based on Central Trust Company's 13F filing for Q4 2024, filed 24 Jan 2025.